BETSEY DECHERT-BOSS: Open Payments
NPI 1619998374 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 24 payments from 11 companies in 2025. Trend: 2023 $239 · 2024 $163 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $102 |
| Lilly USA, LLC | 5 | $91 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Abbott Laboratories | 2 | $49 |
| SANOFI PASTEUR INC. | 2 | $42 |
| Globus Medical, Inc. | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $34 |
| Corcept Therapeutics | 1 | $25 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: Ozempic, MOUNJARO, FREESTYLE LIBRE 3, BEYFORTUS, SHINGRIX, Senza, AIRSUPRA, JARDIANCE.
Industry payments across NY — which companies pay providers there.
